Vortex Genie (VWR) for 40 min at 4°C at maximum speed. Both the bottom and top of the tube were punctured with a hot 22 Gauge needle, taking care that the needle did not contact the lysate, and the tube placed in a 15 ml conical tube. These tubes were spun at 1000 x g for 2 min to separate the lysate from the glass beads, and the lysate was transferred to a new 1.5 ml tube for sonication. The lysate was then sonicated with a microtip probe at an output of 4.5 W for 10 sec. The lysate was spun for 20 min at 4°C at 15,000 x g to remove cell debris and the clarified lysate was transferred to a new tube with 2 ml FA lysis buffer on ice. The final volume was adjusted to 2.5 ml and aliquots of 500 µl were stored at -80°C, with one aliquot used for each Chromatin IP. The sonicated, formaldehyde cross-linked DNA had a modal size of 500 bp with a range of 100 to 5000 bp. Immunoprecipitation followed the methods described by Mallory and Petes and Strahl-Bolsinger et al. (Mallory and Petes, 2000; Strahl-Bolsinger et al., 1997) .
Immunoprecipitations were performed with or without Ab with protein G-Sepharose overnight at 4°C.
Ab's used were anti-HA (F7), anti-myc 9E10 (both from Santa Cruz Biotechnology) and GAL4(DBD) RK5C1
(Santa Cruz Biotechnology) as appropriate. An untagged strain was also used to verify that the Tel1-HAp or Gal4 DBD -Tel1p telomere enrichments in these assays were due to the epitope tag (data not shown). Two methods were used to release the immunoprecipitated chromatin. The first was to incubate the immunoprecipitated (ChIP) samples and an aliquot of the non-immunoprecipitated material (Input) for 6 hr at 65°C to reverse the formaldehyde cross-linking. The second was to incubate the washed immunoprecipitate with the peptide epitope (100 µl of 1 mg/ml in Tris buffered saline) and nutated for 1 hr at 30°C. The supernatant was taken and the beads were resuspended in another 100 µl of peptide solution, the tubes inverted three times by hand and immediately spun down. The supernatant from this second elution was combined with the previous peptide eluant. In the sequential ChIP protocol, this combined supernatant was immediately immunoprecipitated with the second Ab followed by a second peptide elution. DNA was purified as described (Strahl-Bolsinger et al., 1997) , and resuspended in 100 µl of 10 mM Tris 1 mM EDTA pH 7.0.
Semiquantitative PCR analysis was performed using a 1:3000 dilution of the Input DNA sample and 4 additional 3-fold serial dilutions as template in PCR reactions to determine a linear range of amplification.
PCR analysis of ChIP samples used 1:50 and 1:250 dilutions of the ChIP DNA sample to obtain band intensities within the linear range of the above Input DNA dilution series. PCR for the VI-R telomere used primers VIR70S + VIR70AS (Table S2) to produce 269 bp fragment, while PCR for the internal ARO1 and GAL10 loci used primers ARO1S + ARO1AS and GAL10S + GAL10AS (Table S2) , respectively, to yield products of 541 bp and 420 bp, respectively. Primer concentrations were adjusted to yield the same amount of each amplified product using the Input DNA as template, and these concentrations were used for all subsequent PCR analyses. In reactions to quantitate the XV-L telomere, primers ChXV-LS + ChXV-L(AS) were used to produce a 372 bp fragment that was co-amplified with only the ARO1 primers. The amplified DNA fragments were separated on 1.4% agarose gels. The gels were stained with Vistra Green (Amersham Biosciences) and scanned on a Storm 840 (Amersham Biosciences) and the relative levels of each PCR product was determined using ImageQuant software (version 5.2, Amersham Biosciences). Telomere enrichment was calculated as the ratio of the yield of normalized VI-R telomere product over the ratio of normalized internal locus (ARO1 or GAL10) product. While normalization to ARO1 gave the same results as normalization to GAL10 for HA epitope-tagged proteins, only ARO1 could be used as an internal non-specific control locus for Gal4 DBD -tagged proteins because the Gal4 DBD tag binds to sequences near the GAL10 primers. Telomere enrichment was calculated using the formula
where +Ab and -Ab refer to an immunoprecipitation and PCR performed with or without Ab, respectively. Each ChIP PCR was performed and quantitated at least twice.
Telomere PCR Analysis of Telomere Length
DNA samples were treated essentially as in (Förstemann et al., 2000) . DNA samples were denatured and tailed with terminal deoxynucleotide transferase (New England Biolabs) in the presence of dCTP. Poly Ctailed DNA was then PCR amplified using Taq polymerase (Invitrogen) with a primer specific for the subtelomeric region of chromosome VI-R (TELVIR-88, Table S2 ) or XV-L (ChXVL(-230S), Table S2 ) and a primer complimentary to the poly dC-tail (dG 18 -BamHI, Table S2 ). Samples (usually 1 µl (100-200 ng) of genomic DNA or 4 µl of ChIP DNA) were denatured for 2 min at 94°C, then cycled 45 times with 30 seconds of denaturation (94°C), 15 seconds of annealing (63°C) and 30 seconds (for VI-R) or 35 seconds (for XV-L) of extension (72°C) followed by a final extension step of 5 minutes at 72°C. The PCR products were resolved on 2.5 % agarose along side 1 kb Ladder Plus (BRL) markers, stained with Vistra Green (Amersham Biosciences) and scanned on a Storm 840 imager (Amersham Biosciences). Molecular weights of bands on the scanned gels were determined using FragmentNT software (version 1.2, Amersham Biosciences). TG [1] [2] [3] length was determined by subtracting either 114 bp or 256 bp of non-telomeric sequences in the VI-R or XV-L PCR products, respectively, from the average length of the telomere PCR band. Some of these Telomere PCR fragments were cloned and sequenced to verify that the amplified products were copies the telomeric DNA.
Southern Blot Analysis of Telomere Length
Genomic yeast DNA was isolated as described previously (Ray and Runge, 1999b) . For analysis of the VI-R telomere, ~10 µg of this genomic DNA preparation (determined by A 260 of an aliquot of the solution) was digested with 20 units of EcoR V or Stu I (New England Biolabs) and analyzed by Southern blotting using the 32 P-labeled VI-R PCR product (described in Figure S1 ) or the URA3 PCR product (described in Figure S5 ) as probe. Pre-hybridization and hybridization used PerfectHyb (Sigma) according to the instructions of the manufacturer, and the blots were washed according to the same instructions. For analysis of Y' telomeres, DNA was cut with Xho I and the resulting Southern blot was probed with 32 P-labeled TG 1-3 (Ray and Runge, 1998). Fragment sizes were determined using Fragment NT software and mean TG 1-3 lengths were determined by subtracting the known lengths of the non-telomeric DNA sequences from the size of the most intense part of the band.
Gal4-Tel1p alleles for different levels of expression
Tel1p was overexpressed by fusing the strong ADC1 promoter and GAL4 DBD to the 5' end of the TEL1 ORF, and expressing this construct from a multicopy plasmid (called pADC1p::GAL4 DBD -TEL1). This plasmid was constructed in yeast by modifying an existing plasmid bearing the TEL1 gene (pDM197, TEL1 cloned into pRS316, (Morrow et al., 1995) ) by recombination because the TEL1 ORF is toxic to bacteria (Greenwell et al., 1995) . To convert the plasmid pDM197 to pADC1p::GAL4 DBD -TEL1, the ADC1 promoter and GAL4 DBD region from pGBT9 (Clontech) was PCR amplified with the primers 5' Kpn1 pGBT9 + 3' Sac1 pGBT9 (Table S2) , cut with Kpn I and Sac I and cloned into similarly cut pRS424 (Christianson et al., 1992) to form pRSBT. The insert sequence was verified using the primers Kpn1pRSBT and Sac1pRSBT (which hybridize to the insert) (Table S2) , and T7 and T3 (which hybridize to the vector). The pRBST vector was digested with EcoR I and Sal I and used to clone the similarly cut 200 bp PCR product of the 5' TEL1 ORF, obtained using wild type yeast genomic DNA as template using primers 5' TELATG/Eco + 3' TELACT/Sal primers (Table S2) to produce pRSBT-TEL200. The sequence of 200 bp TEL1 insert was verified using the T3 primer. The pRSBT-TEL200 was digested with Sal I and BspH I, and the ADC1-GAL4 DBD -TEL1 fragment was gel isolated and transformed into tel1∆::HIS3 yeast bearing DM197, and Trp + Ura -transformants were selected (where the TRP1 gene of pRSBT-TEL200 replaced the URA3 gene of DM197). The junction in the TEL1 sequence between pRSBT-TEL200 and the rest of the TEL1 ORF was checked by amplification with primers pRS2065 + pRS3880 using the genomic DNA from the presumptive pADC1p::GAL4 DBD -TEL1 transformant as template, purifying the PCR product with the Promega PCR purification kit, and sequencing the junction with TEL1SEQ.
The junction between GAL4 DBD and TEL1 was similarly sequenced by PCR amplifying with GAL4PRS + TEL1PRS using the genomic DNA from the presumptive pADC1p::GAL4 DBD -TEL1 transformant as template, purifying the PCR product and sequencing the junction with GAL4SEQ. Figure S6 ), indicating that the TEL1 ORF in this plasmid encoded a functional protein that could overcome the short telomere phenotype caused by the complete absence of genomic copy of TEL1. The pADC1p::GAL4 DBD -TEL1 plasmid was subsequently transferred to new strains by transformation of genomic DNA derived from cells bearing this plasmid.
The Gal4-Tel1p fusion was also expressed as a single copy gene integrated at the TEL1 locus using either the TEL1 upstream region (i.e. the 0.46 kb of DNA between the TEL1 ORF start and the termination codon of the upstream gene) or the GAL1 upstream region from pFA6a-kanMX-PGAL1 (Longtine et al., 1998).
Briefly, the constructions fused the TEL1 or GAL1 upstream regions to the sequence that encodes Gal4 and the first 240 nt of the TEL1 ORF, and was cloned into pRS306. Both constructs were cleaved in the TEL1 region with BspE I to integrate them into the TEL1 locus of strain W303a to produce TEL1or GAL1 promoter fusions driving Gal4-Tel1p expression. Sequences of the primers used in the construction and to verify the correct integrations are in Table S2 . Plasmid sequences and the cloning strategy are available upon request.
Protein extracts for westerns of the Gal4-Tel1p expressing strains were prepared as described (Osterhage et al., 2006) . Western analysis used anti-Gal4DBD Ab (Santa Cruz RK5C1 sc-510) and Goat antimouse coupled to HRP (Santa Cruz sc-2005).
Yeast bearing GAL1 UAS-promoter -TEL1-HA, EST2-MYC and tel1-HA-kd alleles.
All plasmids in this section with further details of their construction and the location of primers used for construction and confirmation are available upon request.
The TEL1 promoter was replaced with the GAL1 UAS and promoter by amplifying the kanMX-GAL1
upstream region from pFA6a-kanMX-PGAL1 (Longtine et al., 1998) using primers TEL1-A and TEL1-B (Table   S2 ) and using the resulting fragment to transform KRY22 to G418 resistance. The correct integrants were identified by colony PCR using the verification primers in Table S2 .
The KRY22 GAL1-TEL1-HA strain was transformed with Swa I digest pRS304-est2delta-G8-myc18 (Fisher et al., 2004) to form KRY22 GAL1-TEL1-HA EST2-MYC. This plasmid contains the last 528 nt of the EST2 ORF fused to a linker and 18 tandem Myc epitopes in pRS304. The correct integrants were verified using the T7 and T3 primers that border the pRS304 polylinker and EST2 primers just outside the region in the plasmid.
The tel1-HA-kinase dead or tel1-HA-kd strain was made by transforming KRY22 cells with the BgI II digested plasmid pGG114-tel1-kd and identifying the correct transformants by colony PCR with the verification primers shown in Table S2 . This plasmid contains the terminal 1.2 kb of the tel1-kd ORF, amplified from a yeast strain bearing this allele (Mallory and Petes, 2000) containing the mutations that eliminate Tel1p kinase activity, cloned into the pRS304 derivative pGG114. Integration into the TEL1-HA locus replace the 3' portion of the ORF that encodes the kinase domain with the mutant ORF that encodes the kinase dead protein, fusing the kinase dead sequences to the 3 tandem HA epitope coding sequences in TEL1-HA.
Cell Cycle Synchrony
The cell cycle synchronies were performed essentially as described (Spellman et al., 1998) . Briefly, 1.8 l of KRY22 yku70∆ bar1∆ cells (Table S2) were grown in YEPD pH 5.5 at 20°C to an OD660 of 0.2. The cells were arrested in G1 phase by the addition of alpha factor peptide (Sigma) to 12 ng/ml and grown for an additional 3 hours. A 215 ml aliquot of cells was removed for formaldehyde cross-linking for ChIP (200 ml), FACS analysis for DNA content (5 ml) and genomic DNA preparation (10 ml). Cells were then released into the cell cycle by pelleting the cells, washing them once with 200 ml of 20°C YEPD medium and resuspending the washed pellets in 1.6 l of 20°C YEPD pH 5.5. Aliquots were taken at the indicated time points and processed as above. Time points were chosen based on a pilot experiment with a 50 ml culture with FACS analysis of aliquots taken every 5 min. Processing for ChIP followed the protocol described above. FACS analysis was performed by immediately fixing a 5 ml culture aliquot by addition to 10 ml 100% EtOH and processing cells for propidium iodide staining at the Lerner Research Institute Cell Sorting Core Facility.
Aliquots for genomic DNA preparation were held on ice until the end of the cell cycle synchrony and cells were then pelleted, resuspended in 1 ml H 2 O, transferred to an 1.7 ml tube, pelleted, and the supernatant was decanted and the cell pellets frozen for DNA preparation at a later time.
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